Question 1

What is Josh Tarnoff?

Accepted Answer

Josh Tarnoff is a Person.

Question 2

How often does Josh Tarnoff appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Josh Tarnoff first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Josh Tarnoff last mentioned in news?

Accepted Answer

Last active on Apr 14, 2026.

Question 5

What is Josh Tarnoff's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Josh Tarnoff in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Josh Tarnoff?

Accepted Answer

FDA Approves Travere's FILSPARI for FSGS (Apr 13, 2026, 6 articles).

Question 8

How did the "FDA Approves Travere's FILSPARI for FSGS" event impact Josh Tarnoff?

Accepted Answer

Josh Tarnoff, CEO of NephCure Kidney International, stated that FILSPARI's approval is a life-changing moment for FSGS patients and their families, acknowledging the collective efforts that made it possible.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.